Having shown that AKT is activated by CD40 stimulation in CLL cells, we next sought to establish whether activated AKT contributes to the cytoprotective effect of CD40 stimulation against drug-induced killing in stimulated cells. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.